Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
ACOT7	11332	broad.mit.edu	37	1	6341211	6341211	+	Missense_Mutation	SNP	T	T	A			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr1:6341211T>A	ENST00000361521.4	-	8	1956	c.965A>T	c.(964-966)tAc>tTc	p.Y322F	ACOT7_ENST00000545482.1_Missense_Mutation_p.Y217F|ACOT7_ENST00000377845.3_Missense_Mutation_p.Y302F|ACOT7_ENST00000377855.2_Missense_Mutation_p.Y332F|ACOT7_ENST00000377842.3_Missense_Mutation_p.Y281F	NM_007274.3	NP_009205.3	O00154	BACH_HUMAN	acyl-CoA thioesterase 7	332		NA		NA		mitochondrion|nucleus	carboxylesterase activity|fatty-acyl-CoA binding|palmitoyl-CoA hydrolase activity			kidney(1)|large_intestine(3)|lung(10)|pancreas(1)|prostate(1)	16	Ovarian(185;0.0634)|all_lung(157;0.175)	all_cancers(23;1.42e-38)|all_epithelial(116;3.96e-23)|all_lung(118;3.69e-08)|Lung NSC(185;8.52e-07)|all_hematologic(16;6.92e-06)|Colorectal(325;4.53e-05)|Acute lymphoblastic leukemia(12;5e-05)|all_neural(13;0.000164)|Breast(487;0.000688)|Renal(390;0.0007)|Hepatocellular(190;0.00308)|Myeloproliferative disorder(586;0.0255)|Ovarian(437;0.0393)|Medulloblastoma(700;0.211)		Epithelial(90;9.16e-37)|GBM - Glioblastoma multiforme(13;5.89e-29)|OV - Ovarian serous cystadenocarcinoma(86;7.63e-19)|Colorectal(212;1.27e-07)|COAD - Colon adenocarcinoma(227;2.06e-05)|Kidney(185;7.74e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00129)|BRCA - Breast invasive adenocarcinoma(365;0.00132)|STAD - Stomach adenocarcinoma(132;0.00195)|READ - Rectum adenocarcinoma(331;0.0481)		CAGCGACACGTAGGTGAAGAA	0.642		NA				NA		NA			OREG0013034	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(74;673 1226 4974 11850 13190)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				62	54	57	NA	NA	NA	NA	1		NA								NA			NA		NA	NA	6341211		2203	4300	6503	SO:0001583	missense			ENSG00000097021	HGNC:24157	NM_007274	Approved	uc001amt.3	633	A8K0K7|A8K232|A8K6B8|A8K837|O43703|Q53Y78|Q5JYL2|Q5JYL3|Q5JYL4|Q5JYL5|Q5JYL6|Q5TGR4|Q9UJM9|Q9Y539|Q9Y540	ENST00000361521.4	37	CCDS30573.1	.	.	.	.	.	.	.	.	.	.	T	7.326	0.618013	0.14129	.	.	ENSG00000097021	ENST00000377855;ENST00000377845;ENST00000377842;ENST00000361521;ENST00000545482	T;T;T;T;T	0.36878	1.23;1.23;1.23;1.23;1.23	4.69	4.69	0.59074	.	0.070963	0.64402	D	0.000016	T	0.17831	0.0428	N	0.08118	0	0.80722	D	1	B;B;B;B	0.20052	0.006;0.005;0.041;0.001	B;B;B;B	0.22152	0.007;0.005;0.038;0.007	T	0.06972	-1.0797	10	0.06099	T	0.92	.	13.3346	0.60509	0.0:0.0:0.0:1.0	.	322;332;302;281	B3KQ12;O00154;O00154-5;O00154-6	.;BACH_HUMAN;.;.	F	332;302;281;322;217	ENSP00000367086:Y332F;ENSP00000367076:Y302F;ENSP00000367073:Y281F;ENSP00000354615:Y322F;ENSP00000439218:Y217F	ENSP00000354615:Y322F	Y	-	2	0	ACOT7	6263798	1.000000	0.71417	0.994000	0.49952	0.742000	0.42306	3.805000	0.55575	1.744000	0.51775	0.459000	0.35465	TAC	ACOT7-006	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000003778.2	53.011889	KEEP		-	53.945749	0.358491	19	34	---	---	---	---	1	1	50	48	0	57	20	35	0	57	2	0	0	0	0	0	0	20	35	0	57	2	TP
SIKE1	80143	broad.mit.edu	37	1	115321764	115321764	+	Splice_Site	SNP	G	G	A			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr1:115321764G>A	ENST00000369528.5	-	3	496	c.420_splice	c.e3+1	p.A140_splice	SIKE1_ENST00000506320.1_5'UTR|SIKE1_ENST00000060969.5_Splice_Site_p.A136_splice	NM_001102396.1|NM_025073.2	NP_001095866.1|NP_079349.2	Q9BRV8	SIKE1_HUMAN	suppressor of IKBKE 1	136		NA		NA		cytosol	protein binding			endometrium(1)|kidney(2)|large_intestine(1)|lung(2)	6						GTTTCTTACTGCAGAGTGAGA	0.378		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				141	145	144	NA	NA	NA	NA	1		NA								NA			NA		NA	NA	115321764		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000052723	HGNC:26119	NM_025073	Approved	uc001efp.4	NA	Q5TEZ7|Q5TEZ9|Q68DZ4|Q9H778	ENST00000369528.5	37	CCDS41371.1	.	.	.	.	.	.	.	.	.	.	G	14.81	2.646768	0.47258	.	.	ENSG00000052723	ENST00000369528;ENST00000060969	T;T	0.68903	-0.36;-0.36	6.17	5.09	0.68999	.	0.303964	0.40554	N	0.001061	T	0.22044	0.0531	N	0.02011	-0.69	0.80722	D	1	B;B	0.10296	0.002;0.003	B;B	0.08055	0.003;0.003	T	0.15665	-1.0429	10	0.45353	T	0.12	-7.7221	7.6281	0.28224	0.0751:0.1222:0.6771:0.1256	.	140;136	Q9BRV8-2;Q9BRV8	.;SIKE1_HUMAN	V	140;136	ENSP00000358541:A140V;ENSP00000060969:A136V	ENSP00000060969:A136V	A	-	2	0	SIKE1	115123287	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	0.913000	0.28611	2.941000	0.99782	0.655000	0.94253	GCA	SIKE1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033402.1	49.634859	KEEP	Missense_Mutation	-	50.498163	0.36	18	32	---	---	---	---	1	0.9998349	16	18	0	85	19	36	0	85	2	0	1	0	126	1	198	19	36	0	85	4	TP
AKAP12	9590	broad.mit.edu	37	6	151671522	151671522	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr6:151671522C>A	ENST00000402676.2	+	4	2236	c.1996C>A	c.(1996-1998)Ccg>Acg	p.P666T	AKAP12_ENST00000354675.6_Missense_Mutation_p.P568T|AKAP12_ENST00000253332.1_Missense_Mutation_p.P666T|AKAP12_ENST00000359755.5_Missense_Mutation_p.P561T	NM_005100.3	NP_005091.2	Q02952	AKA12_HUMAN	A kinase (PRKA) anchor protein 12	666		NA		NA	G-protein coupled receptor protein signaling pathway|positive regulation of cAMP biosynthetic process|positive regulation of protein kinase A signaling cascade|protein targeting	cell cortex|cytoskeleton|plasma membrane	adenylate cyclase binding|protein kinase A binding			breast(3)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(22)|lung(22)|ovary(2)|pancreas(1)|prostate(2)|skin(4)|stomach(1)|upper_aerodigestive_tract(1)	68		Ovarian(120;0.125)	BRCA - Breast invasive adenocarcinoma(37;0.175)	OV - Ovarian serous cystadenocarcinoma(155;2.98e-11)		AGAGCCAAAGCCGGAAGAACC	0.493		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(141;1616 1805 10049 24534 51979)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				84	81	82	NA	NA	NA	NA	6		NA								NA			NA		NA	NA	151671522		2203	4300	6503	SO:0001583	missense			ENSG00000131016	HGNC:370		Approved	uc011eep.2	NA	O00310|O00498|Q4LE68|Q5SZ80|Q5TGN1|Q68D82|Q99970	ENST00000402676.2	37	CCDS5229.1	.	.	.	.	.	.	.	.	.	.	C	6.497	0.459964	0.12342	.	.	ENSG00000131016	ENST00000402676;ENST00000253332;ENST00000354675;ENST00000359755	T;T;T;T	0.05649	3.41;3.41;3.42;3.42	5.31	2.1	0.27182	.	0.195349	0.25651	N	0.029205	T	0.01061	0.0035	N	0.25890	0.77	0.24255	N	0.995306	B;B;B	0.33940	0.394;0.433;0.307	B;B;B	0.27887	0.068;0.084;0.038	T	0.48822	-0.9001	10	0.21014	T	0.42	.	4.9784	0.14153	0.1448:0.6038:0.1034:0.148	.	561;568;666	Q02952-3;Q02952-2;Q02952	.;.;AKA12_HUMAN	T	666;666;568;561	ENSP00000384537:P666T;ENSP00000253332:P666T;ENSP00000346702:P568T;ENSP00000352794:P561T	ENSP00000253332:P666T	P	+	1	0	AKAP12	151713215	0.786000	0.28738	0.039000	0.18376	0.137000	0.21094	0.007000	0.13174	0.565000	0.29255	0.650000	0.86243	CCG	AKAP12-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		44.15304	KEEP		+	46.226917	0.298246	17	40	---	---	---	---	1	0.9992729	11	21	0	80	18	40	0	80	2	0	0	0	0	0	0	18	40	0	80	2	TP
RELN	5649	broad.mit.edu	37	7	103202062	103202062	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr7:103202062G>T	ENST00000428762.1	-	36	5605	c.5446C>A	c.(5446-5448)Ctt>Att	p.L1816I	RELN_ENST00000424685.2_Missense_Mutation_p.L1816I|RELN_ENST00000343529.5_Missense_Mutation_p.L1816I	NM_005045.3	NP_005036.2	P78509	RELN_HUMAN	reelin	1816		NA		NA	axon guidance|cell adhesion|cerebral cortex tangential migration|glial cell differentiation|neuron migration|peptidyl-tyrosine phosphorylation|positive regulation of protein kinase activity|positive regulation of small GTPase mediated signal transduction|response to pain|spinal cord patterning	cytoplasm|dendrite|extracellular space|proteinaceous extracellular matrix	metal ion binding|protein serine/threonine/tyrosine kinase activity|serine-type peptidase activity			NS(3)|breast(8)|central_nervous_system(3)|cervix(1)|endometrium(13)|haematopoietic_and_lymphoid_tissue(4)|kidney(6)|large_intestine(43)|lung(101)|ovary(9)|pancreas(2)|prostate(4)|skin(14)|stomach(2)|upper_aerodigestive_tract(12)|urinary_tract(2)	227				COAD - Colon adenocarcinoma(1;8.98e-05)|Colorectal(1;0.00184)		TCAGGCCAAAGGTCAGGATGT	0.443		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(146;835 1944 15585 22231 52158)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				111	109	110	NA	NA	NA	NA	7		NA								NA			NA		NA	NA	103202062		2203	4300	6503	SO:0001583	missense			ENSG00000189056	HGNC:9957	NM_005045	Approved	uc010liz.3	NA	A4D0P9|A4D0Q0|Q86UJ0|Q86UJ8|Q8NDV0|Q9UDQ2	ENST00000428762.1	37	CCDS47680.1	.	.	.	.	.	.	.	.	.	.	G	16.84	3.234325	0.58886	.	.	ENSG00000189056	ENST00000428762;ENST00000343529;ENST00000424685;ENST00000448171	T;T;T	0.24723	1.84;1.84;1.84	5.86	4.98	0.66077	Neuraminidase (1);	0.200755	0.44902	N	0.000402	T	0.45458	0.1343	L	0.50333	1.59	0.36883	D	0.889511	P;D	0.59767	0.868;0.986	P;D	0.70227	0.57;0.968	T	0.52518	-0.8565	10	0.48119	T	0.1	.	16.4028	0.83647	0.0:0.0:0.8671:0.1329	.	1816;1816	P78509-2;P78509	.;RELN_HUMAN	I	1816	ENSP00000392423:L1816I;ENSP00000345694:L1816I;ENSP00000388446:L1816I	ENSP00000345694:L1816I	L	-	1	0	RELN	102989298	1.000000	0.71417	0.999000	0.59377	0.962000	0.63368	5.602000	0.67612	1.475000	0.48197	0.563000	0.77884	CTT	RELN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348148.1	31.481036	KEEP		-	33.529264	0.272727	12	32	---	---	---	---	0	0	0	1	0	88	12	35	0	88	2	1	1	129	217	1	460	12	35	0	88	5	TP
METTL2B	55798	broad.mit.edu	37	7	128142023	128142023	+	3'UTR	SNP	A	A	T	rs12539729	by1000genomes	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr7:128142023A>T	ENST00000480046.1	+	0	1110				METTL2B_ENST00000262432.8_3'UTR			Q6P1Q9	MTL2B_HUMAN	methyltransferase like 2B	NA		NA		NA			methyltransferase activity			breast(1)|cervix(1)|large_intestine(2)|lung(10)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	17						GAGCTTTTTTAAAAAAAAATT	0.537		NA				NA		NA					A	1058	0.48	0.46	0.46	2184	0.37	0.9796	,	,	NA	0.0093	0.6	NA	NA	0.4809	0.9719	LOWCOV	NA	NA	0.0026	SNP		NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				NA	NA	NA	NA	NA	NA	NA			NA								NA			NA		NA	NA	NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000165055	HGNC:18272	NM_018396	Approved	uc003vnf.3	NA	B4DZ68|Q0IJ54|Q3B7J1	ENST00000480046.1	37																																																																																				METTL2B-002	NOVEL	basic	protein_coding	NA	protein_coding	OTTHUMT00000289818.2	-12.705442	KEEP		+	8.501324	0.050505	5	94	---	---	---	---	1	0.6818955	6	40	0	99	5	100	0	99	2	0	0	0	0	0	0	5	100	0	99	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)	NA	NA	NA	NA	NA		NA				112	104	107	NA	NA	NA	NA	7		NA								NA			NA		NA	NA	140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	33.892009	KEEP		-	34.330946	0.375	12	20	---	---	---	---	1	0.9991908	14	14	0	31	14	24	0	31	2	1	1	94	177	1	412	14	24	0	31	5	TP
PPAPDC2	403313	broad.mit.edu	37	9	4662753	4662753	+	Silent	SNP	G	G	C			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr9:4662753G>C	ENST00000381883.2	+	1	456	c.378G>C	c.(376-378)tcG>tcC	p.S126S	SPATA6L_ENST00000454239.2_Intron|SPATA6L_ENST00000223517.5_Intron|SPATA6L_ENST00000381895.5_Intron|SPATA6L_ENST00000381890.5_Intron|SPATA6L_ENST00000475086.1_Intron	NM_203453.3	NP_982278.3	Q8IY26	PPAC2_HUMAN	phosphatidic acid phosphatase type 2 domain containing 2	126		NA		NA		integral to membrane	hydrolase activity			endometrium(1)|large_intestine(2)|lung(1)	4	all_hematologic(13;0.137)	Breast(48;0.238)		GBM - Glioblastoma multiforme(50;0.026)		AGAGCTCGTCGTGGGGCAGCG	0.657		NA				NA		NA			OREG0019084	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(187;1057 3809 8526)	NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				49	48	48	NA	NA	NA	NA	9		NA								NA			NA		NA	NA	4662753		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000205808	HGNC:23682	NM_203453	Approved	uc003zin.4	620	B3KY05|Q5JVJ6|Q8NCK9	ENST00000381883.2	37	CCDS34981.1																																																																																			PPAPDC2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051567.1	-0.105135	KEEP		+	7.305499	0.075	3	37	---	---	---	---	1	0.8696354	18	22	0	49	4	40	0	49	2	0	0	0	0	0	0	4	40	0	49	2	TP
SVEP1	79987	broad.mit.edu	37	9	113234582	113234582	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr9:113234582G>A	ENST00000401783.2	-	15	2957	c.2621C>T	c.(2620-2622)gCt>gTt	p.A874V	SVEP1_ENST00000467821.1_5'UTR|SVEP1_ENST00000302728.8_Missense_Mutation_p.A874V|SVEP1_ENST00000374469.1_Missense_Mutation_p.A851V	NM_153366.3	NP_699197.3	Q4LDE5	SVEP1_HUMAN	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	874		NA		NA	cell adhesion	cytoplasm|extracellular region|membrane	calcium ion binding			NS(1)|autonomic_ganglia(1)|breast(5)|central_nervous_system(1)|cervix(2)|endometrium(19)|kidney(8)|large_intestine(24)|lung(58)|ovary(7)|prostate(7)|skin(1)|stomach(4)|upper_aerodigestive_tract(5)|urinary_tract(4)	147						CAGCCTATTAGCTGCACCCCA	0.493		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				72	75	74	NA	NA	NA	NA	9		NA								NA			NA		NA	NA	113234582		2025	4188	6213	SO:0001583	missense			ENSG00000165124	HGNC:15985		Approved	uc010mtz.3	NA	Q0P675|Q5D213|Q5T938|Q5VTE4|Q5VTE5|Q7Z387|Q7Z3G3|Q8NBT9|Q96JU7|Q9H284|Q9H8J9	ENST00000401783.2	37	CCDS48004.1	.	.	.	.	.	.	.	.	.	.	G	20.8	4.046855	0.75846	.	.	ENSG00000165124	ENST00000401783;ENST00000374469;ENST00000302728	T;T;T	0.78924	-1.04;-1.04;-1.22	5.25	4.33	0.51752	.	0.345027	0.30742	N	0.008964	T	0.77572	0.4150	M	0.63428	1.95	0.26491	N	0.974944	P;P	0.46912	0.886;0.813	P;B	0.45377	0.478;0.259	T	0.69826	-0.5040	10	0.27785	T	0.31	.	15.4136	0.74945	0.0:0.1445:0.8555:0.0	.	874;874	E9PBN8;Q4LDE5	.;SVEP1_HUMAN	V	874;851;874	ENSP00000384917:A874V;ENSP00000363593:A851V;ENSP00000304118:A874V	ENSP00000304118:A874V	A	-	2	0	SVEP1	112274403	0.987000	0.35691	0.709000	0.30452	0.894000	0.52154	1.741000	0.38238	1.187000	0.43000	0.650000	0.86243	GCT	SVEP1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		5.074258	KEEP		-	15.250983	0.106061	7	59	---	---	---	---	0	0	0	0	0	59	8	59	0	59	2	1	1	46	542	0	792	8	59	0	59	2	TP
FGFR2	2263	broad.mit.edu	37	10	123279544	123279544	+	Missense_Mutation	SNP	C	C	G			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr10:123279544C>G	ENST00000358487.5	-	7	1160	c.888G>C	c.(886-888)aaG>aaC	p.K296N	FGFR2_ENST00000369056.1_Missense_Mutation_p.K296N|FGFR2_ENST00000478859.1_Missense_Mutation_p.K68N|FGFR2_ENST00000369059.1_Missense_Mutation_p.K181N|FGFR2_ENST00000360144.3_Missense_Mutation_p.K207N|FGFR2_ENST00000346997.2_Missense_Mutation_p.K296N|FGFR2_ENST00000369061.4_Intron|FGFR2_ENST00000369060.4_Missense_Mutation_p.K296N|FGFR2_ENST00000351936.6_Missense_Mutation_p.K296N|FGFR2_ENST00000490349.1_5'UTR|FGFR2_ENST00000457416.2_Missense_Mutation_p.K296N|FGFR2_ENST00000356226.4_Missense_Mutation_p.K181N|FGFR2_ENST00000357555.5_Missense_Mutation_p.K207N	NM_000141.4	NP_000132.3	P21802	FGFR2_HUMAN	fibroblast growth factor receptor 2	296	Ig-like C2-type 3.	NA		NA	angiogenesis|axonogenesis|bone mineralization|bone morphogenesis|branch elongation involved in salivary gland morphogenesis|branching involved in embryonic placenta morphogenesis|branching morphogenesis of a nerve|bud elongation involved in lung branching|cell fate commitment|cell growth|cell-cell signaling|cellular response to protein stimulus|embryonic digestive tract morphogenesis|embryonic pattern specification|epithelial cell proliferation involved in salivary gland morphogenesis|fibroblast growth factor receptor signaling pathway involved in hemopoiesis|fibroblast growth factor receptor signaling pathway involved in mammary gland specification|fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptosis in bone marrow|fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development|fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow|hair follicle morphogenesis|insulin receptor signaling pathway|lacrimal gland development|lateral sprouting from an epithelium|limb bud formation|lung alveolus development|lung lobe morphogenesis|lung-associated mesenchyme development|mammary gland bud formation|membranous septum morphogenesis|mesenchymal cell differentiation involved in lung development|mesenchymal cell proliferation involved in lung development|midbrain development|multicellular organism growth|negative regulation of transcription from RNA polymerase II promoter|odontogenesis|organ growth|otic vesicle formation|outflow tract septum morphogenesis|positive regulation of canonical Wnt receptor signaling pathway|positive regulation of cardiac muscle cell proliferation|positive regulation of cell cycle|positive regulation of cell division|positive regulation of epithelial cell proliferation involved in lung morphogenesis|positive regulation of ERK1 and ERK2 cascade|positive regulation of mesenchymal cell proliferation|positive regulation of transcription from RNA polymerase II promoter|post-embryonic development|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate epithelial cord elongation|pyramidal neuron development|regulation of branching involved in prostate gland morphogenesis|regulation of cell fate commitment|regulation of fibroblast growth factor receptor signaling pathway|regulation of multicellular organism growth|regulation of smooth muscle cell differentiation|regulation of smoothened signaling pathway|squamous basal epithelial stem cell differentiation involved in prostate gland acinus development|ureteric bud development|ventricular cardiac muscle tissue morphogenesis|ventricular zone neuroblast division	cell cortex|cell surface|excitatory synapse|extracellular region|integral to membrane|nucleus|plasma membrane	ATP binding|fibroblast growth factor binding|fibroblast growth factor receptor activity|heparin binding|protein binding			breast(3)|central_nervous_system(3)|cervix(2)|endometrium(98)|haematopoietic_and_lymphoid_tissue(4)|kidney(4)|large_intestine(7)|lung(21)|ovary(4)|skin(30)|soft_tissue(1)|stomach(2)|upper_aerodigestive_tract(2)	181		Lung NSC(174;0.0841)|all_lung(145;0.106)|all_neural(114;0.107)	STAD - Stomach adenocarcinoma(1;7.52e-05)|all cancers(1;0.0722)	all cancers(201;9.73e-05)|GBM - Glioblastoma multiforme(135;0.0845)	Palifermin(DB00039)	TACTGCCGTTCTTTTCCACGT	0.537		5	Mis		"""gastric. NSCLC, endometrial"""	NA	"""Crouzon, Pfeiffer, and Apert syndromes"""	NA	Saethre-Chotzen syndrome;Apert syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA	Dom	yes	NA	10	10q26	2263	fibroblast growth factor receptor 2	yes	E	0			NA	NA	NA	NA	NA		NA				128	121	123	NA	NA	NA	NA	10		NA								NA			NA		NA	NA	123279544		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Acrocephalosyndactyly type III;Acrocephalosyndactyly type I and II, ACS1. ACS2, incl Apert-Crouzon s.	ENSG00000066468	HGNC:3689	NM_022976, NM_000141	Approved	uc021pzy.1	NA	P18443|Q01742|Q12922|Q14300|Q14301|Q14302|Q14303|Q14304|Q14305|Q14672|Q14718|Q14719|Q1KHY5|Q86YI4|Q96KL9|Q96KM0|Q96KM1|Q96KM2|Q9NZU2|Q9NZU3|Q9UD01|Q9UD02|Q9UIH3|Q9UIH4|Q9UIH5|Q9UIH6|Q9UIH7|Q9UIH8|Q9UM87|Q9UMC6|Q9UNS7|Q9UQH7|Q9UQH8|Q9UQH9|Q9UQI0	ENST00000358487.5	37	CCDS31298.1	.	.	.	.	.	.	.	.	.	.	C	13.97	2.396087	0.42512	.	.	ENSG00000066468	ENST00000357555;ENST00000369062;ENST00000358487;ENST00000356226;ENST00000369060;ENST00000369059;ENST00000346997;ENST00000457416;ENST00000351936;ENST00000360144;ENST00000369056;ENST00000369058;ENST00000336553	T;T;T;D;T;T;T;T;T;T;T;T	0.95853	-0.34;-0.34;-0.34;-3.83;-0.34;-0.34;-0.34;-0.34;-0.34;-0.34;-0.34;-0.34	5.79	5.79	0.91817	.	0.188800	0.56097	D	0.000034	D	0.91865	0.7425	N	0.16368	0.405	0.58432	D	0.999998	B;B;P;B;B;B;B;B;B;B	0.43287	0.076;0.003;0.802;0.002;0.003;0.015;0.12;0.247;0.001;0.303	B;B;B;B;B;B;B;B;B;B	0.41619	0.082;0.027;0.361;0.016;0.006;0.076;0.139;0.205;0.007;0.241	D	0.91388	0.5133	10	0.37606	T	0.19	.	20.0368	0.97565	0.0:1.0:0.0:0.0	.	315;181;296;315;296;207;181;315;207;296	D3DRD4;B5A963;B5A960;D3DRD5;P21802-18;P21802-21;P21802-20;D3DRE0;P21802-22;P21802-17	.;.;.;.;.;.;.;.;.;.	N	207;296;296;181;296;181;296;296;296;207;296;296;207	ENSP00000350166:K207N;ENSP00000351276:K296N;ENSP00000348559:K181N;ENSP00000358056:K296N;ENSP00000358055:K181N;ENSP00000263451:K296N;ENSP00000410294:K296N;ENSP00000309878:K296N;ENSP00000353262:K207N;ENSP00000358052:K296N;ENSP00000358054:K296N;ENSP00000337665:K207N	ENSP00000337665:K207N	K	-	3	2	FGFR2	123269534	1.000000	0.71417	1.000000	0.80357	0.991000	0.79684	2.112000	0.41892	2.735000	0.93741	0.563000	0.77884	AAG	FGFR2-001	KNOWN	non_canonical_conserved|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050715.1	6.037914	KEEP		-	18.826901	0.1	8	72	---	---	---	---	1	0.9970769	11	86	0	96	9	78	0	96	2	0	0	0	0	0	0	9	78	0	96	2	TP
VPS11	55823	broad.mit.edu	37	11	118951865	118951865	+	Silent	SNP	C	C	G			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr11:118951865C>G	ENST00000300793.6	+	16	2541	c.2499C>G	c.(2497-2499)gtC>gtG	p.V833V	VPS11_ENST00000527798.1_3'UTR	NM_021729.4	NP_068375.3	Q9H270	VPS11_HUMAN	vacuolar protein sorting 11 homolog (S. cerevisiae)	834		NA		NA	protein transport	endocytic vesicle|HOPS complex|late endosome membrane|lysosomal membrane	nucleotide binding|protein binding|zinc ion binding			autonomic_ganglia(1)|central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(6)|lung(7)|ovary(2)|prostate(1)|skin(2)|urinary_tract(2)	29	all_hematologic(175;0.0839)	Medulloblastoma(222;0.0425)|Breast(348;0.052)|all_neural(223;0.112)		BRCA - Breast invasive adenocarcinoma(274;7.88e-05)		TGCCCTCAGTCCACTTCCTGT	0.507		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				252	254	253	NA	NA	NA	NA	11		NA								NA			NA		NA	NA	118951865		2063	4200	6263	SO:0001819	synonymous_variant				HGNC:14583	NM_021729	Approved	uc010ryx.2	NA	Q8WY89|Q96EP8|Q9H6D9|Q9HCS6	ENST00000300793.6	37																																																																																				VPS11-201	KNOWN	basic	protein_coding	NA	protein_coding		-10.536019	KEEP		+	26.115086	0.064516	12	174	---	---	---	---	1	0.9982561	15	162	0	278	12	190	0	278	2	0	0	0	0	0	0	12	190	0	278	2	TP
ZNRF3	84133	broad.mit.edu	37	22	29446145	29446145	+	Missense_Mutation	SNP	C	C	G			THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-MK-A4N7-Tumor-SM-3UTEY	THCA-TCGA-MK-A4N7-Normal-SM-3UTGV	g.chr22:29446145C>G	ENST00000544604.2	+	8	2151	c.1976C>G	c.(1975-1977)tCc>tGc	p.S659C	ZNRF3_ENST00000402174.1_Missense_Mutation_p.S559C|ZNRF3_ENST00000406323.3_Missense_Mutation_p.S559C|ZNRF3_ENST00000332811.4_Missense_Mutation_p.S559C	NM_001206998.1	NP_001193927.1	Q9ULT6	ZNRF3_HUMAN	zinc and ring finger 3	659		NA		NA		integral to membrane	zinc ion binding			NS(1)|breast(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|liver(4)|lung(9)|ovary(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(2)	28						GATCAGGTGTCCACCTGCAGC	0.682		NA				NA		NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0			NA	NA	NA	NA	NA		NA				43	49	47	NA	NA	NA	NA	22		NA								NA			NA		NA	NA	29446145		2014	4160	6174	SO:0001583	missense			ENSG00000183579	HGNC:18126	XM_290972	Approved	uc003aeg.3	NA	Q6ICH1|Q6NTF8|Q8WU18	ENST00000544604.2	37	CCDS56225.1	.	.	.	.	.	.	.	.	.	.	C	21.8	4.195094	0.78902	.	.	ENSG00000183579	ENST00000544604;ENST00000332811;ENST00000462485;ENST00000402174;ENST00000406323	T;T;T;T	0.80033	-1.33;-1.33;-1.33;-1.33	5.55	5.55	0.83447	.	0.000000	0.85682	D	0.000000	D	0.89150	0.6633	M	0.65498	2.005	0.58432	D	0.999998	D	0.89917	1.0	D	0.91635	0.999	D	0.89829	0.3994	10	0.87932	D	0	-37.608	18.4931	0.90854	0.0:1.0:0.0:0.0	.	659	Q9ULT6	ZNRF3_HUMAN	C	659;559;366;559;559	ENSP00000443824:S659C;ENSP00000328614:S559C;ENSP00000384456:S559C;ENSP00000384553:S559C	ENSP00000328614:S559C	S	+	2	0	ZNRF3	27776145	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	7.098000	0.76974	2.603000	0.88011	0.650000	0.86243	TCC	ZNRF3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000320943.2	2.996075	KEEP		+	19.969878	0.09	9	91	---	---	---	---	1	0.8598906	4	37	0	106	9	98	0	106	2	0	0	0	0	0	0	9	98	0	106	2	TP
